Venus Remedies awarded Saudi GMP approval for all its Production Facilities at Baddi

Venus Remedies Limited has has received good manufacturing practices (GMP) certification from Saudi Arabia for all its production facilities at its unit in Baddi, Himachal Pradesh.

The Saudi Food and Drug Authority (SFDA) granted the certification, which included first-time approval for pre-filled Enoxaparin syringes and general injection facilities, and renewed approval for Cephalosporin and Carbapenem antibiotics and liquid and lyophilised oncology drugs, after an extensive review and audit of the company's facilities.

Shares of Venus Remedies Limited was last trading in BSE at Rs. 160.70 as compared to the previous close of Rs. 170.05. The total number of shares traded during the day was 11269 in over 613 trades.

The stock hit an intraday high of Rs. 173.25 and intraday low of 159.20. The net turnover during the day was Rs. 1884832.00.

Source : Equity Bulls

Keywords

VenusRemedies INE411B01019 Pharmaceuticals Saudi GMPApproval ProductionFacilities Baddi HimachalPradesh